HomeONCY • NASDAQ
add
Oncolytics Biotech Inc
Nakaraang pagsara
$0.94
Sakop ng araw
$0.92 - $0.98
Sakop ng taon
$0.84 - $1.73
Market cap
74.10M USD
Average na Volume
400.11K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 9.90M | -10.40% |
Net na kita | -9.54M | 3.85% |
Net profit margin | — | — |
Kita sa bawat share | -0.12 | 10.29% |
EBITDA | -9.86M | 10.56% |
Aktuwal na % ng binabayarang buwis | -0.13% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 19.60M | -50.98% |
Kabuuang asset | 24.26M | -47.36% |
Kabuuang sagutin | 15.20M | -10.93% |
Kabuuang equity | 9.06M | — |
Natitirang share | 77.07M | — |
Presyo para makapag-book | 7.79 | — |
Return on assets | -87.86% | — |
Return on capital | -167.51% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -9.54M | 3.85% |
Cash mula sa mga operasyon | -4.83M | 19.87% |
Cash mula sa pag-invest | -32.00K | -100.47% |
Cash mula sa financing | -173.00K | -100.81% |
Net change in cash | -5.25M | -123.38% |
Malayang cash flow | -1.70M | -171.09% |
Tungkol
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Itinatag
1998
Headquarters
Website
Mga Empleyado
29
